Bend Memorial Clinic has ongoing clinical trials. We currently have three trials going on in regards to breast cancer. If you or someone you know is interested in participating in one of these studies, please call us (877) 692-8338.
BMC Breast Cancer Clinical Trials
Indication: Breast Cancer, Starting Chemotherapy
Summary: Comparing Naproxen (Aleve) or Loratadine (Claritin) to relieve bone pain in breast Cancer patients receiving Chemo and Pegfilgrastim
Eligibility: Females with newly diagnosed, not previously treated with chemotherapy, stage I-III breast cancer.
For more information: Christine Reed, 541-318-3137 or creed@bmctotalcare.com
Indication: Breast Cancer, Starting Chemotherapy
Summary: Comparing educational DVDs to see if education can relieve bone pain in breast cancer patients receiving Chemo and Pegfilgrastim.
Eligibility: Females with newly diagnosed, not previously treated with chemotherapy, stage I-III breast cancer.
For more information: Christine Reed, 541-318-3137 or creed@bmctotalcare.com
Indication: Breast Biopsy
Summary: Single blood draw of women undergoing breast biopsy. Goal is to develop a blood test that could replace biopsy in certain patients. Patients must have no history of cancer.
Eligibility: Women age 18 and over who have had a suspicious mammogram and are scheduled for breast biopsy.
For more information: Jennifer McCormick, 541-322-3538 or jmccormick@bmctotalcare.com
